Literature DB >> 15735808

Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association.

Karen A Moffat1, Marlies R Ledford-Kraemer, William L Nichols, Catherine P M Hayward.   

Abstract

Disorders of platelet function are important causes of abnormal bleeding that require laboratory tests for diagnosis. Currently there are limited guidelines on how to perform clinical testing for these disorders. The goal of our study was to obtain information on how disorders of platelet function are currently evaluated in clinical laboratories. Two patterns-of-practice surveys were distributed to laboratories of the North American Specialized Coagulation Laboratory Association (NASCOLA). The information collected was analyzed to determine practices and common problems. Forty-seven NASCOLA laboratories participated and 54% completed both surveys. The majority of the laboratories that responded performed more than 50 aggregation tests per year, mainly using platelet rich plasma based methodologies. A minority performed testing for platelet secretion and dense granule abnormalities. While platelet aggregation results were reviewed in various ways, laboratories most commonly issued a combined report containing quantitative values (% aggregation and/or slope) and a qualitative interpretation. Although laboratories used similar agonists for aggregation testing, the final agonist concentrations varied widely. Several approaches were also used to obtain reference intervals. Comments offered by the participants indicated that performing, and interpreting platelet function tests were challenging for many clinical laboratories. Although common practices have evolved, there is considerable variability in the diagnostic test procedures used by clinical laboratories to evaluate disorders of platelet function. These patterns-of-practice surveys illustrate a need for guidelines and recommendations for clinical laboratories performing tests of platelet function.

Entities:  

Mesh:

Year:  2005        PMID: 15735808     DOI: 10.1160/TH04-10-0670

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements.

Authors:  H Mani; B Luxembourg; C Kläffling; M Erbe; E Lindhoff-Last
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

2.  Strategies in Clinical and Laboratory Diagnosis of Inherited Platelet Function Disorders in Children.

Authors:  Ralf Knöfler; Werner Streif
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

3.  Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy.

Authors:  Dietmar Enko; Harald Mangge; Andreas Münch; Tobias Niedrist; Elisabeth Mahla; Helfried Metzler; Florian Prüller
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313

4.  Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency.

Authors:  Ivar van Asten; Maaike Blaauwgeers; Lianne Granneman; Harry F G Heijnen; Marieke J H A Kruip; Erik A M Beckers; Michiel Coppens; Jeroen Eikenboom; Rienk Y J Tamminga; Gerard Pasterkamp; Albert Huisman; Karin P M van Galen; Suzanne J A Korporaal; Roger E G Schutgens; Rolf T Urbanus
Journal:  J Thromb Haemost       Date:  2019-12-27       Impact factor: 5.824

5.  Influencing Factors and Differences in Born Aggregometry in Specialized Hemostaseological Centers: Results of a Multicenter Laboratory Comparison.

Authors:  Thorsten Kaiser; Karin Liebscher; Ute Scholz; Christian Pfrepper; Jeffrey Netto; Tim Drogies; Oliver Tiebel; Ralf Knöfler; Michael Krause
Journal:  TH Open       Date:  2022-08-22

6.  Platelet function testing: Current practice among clinical centres in Northern Europe.

Authors:  Timea Szanto; Eva Zetterberg; Sofia Ramström; Eva B Leinøe; Pål A Holme; Jovan P Antovic; Margareta Holmström; Pall T Onundarson; Marika Pikta; Ines Vaide; Anna Olsson; Maria Magnusson; Satu Kärkkäinen; Manar Bitar; Lone Hvitfeldt Poulsen; Riitta Lassila
Journal:  Haemophilia       Date:  2022-05-05       Impact factor: 4.263

7.  Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay.

Authors:  Marie Lordkipanidzé; Gillian C Lowe; Nicholas S Kirkby; Melissa V Chan; Martina H Lundberg; Neil V Morgan; Danai Bem; Shaista P Nisar; Vincenzo C Leo; Matthew L Jones; Stuart J Mundell; Martina E Daly; Andrew D Mumford; Timothy D Warner; Steve P Watson
Journal:  Blood       Date:  2014-01-09       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.